Polylactic acid and polyglycolic acid are part of a chemical family referred to as alpha esters. 2, 8 These alpha ester compounds have been used successfully as suture material over the past 30 years. 6, 9 Resorbable polymers, especially the alpha ester polymer group, have been used successfully in various orthopedic and craniofacial applications with increasing frequency over the past 15 years. 2, 5, 8 Polylactic acid and polyglycolic acid are made by condensation polymerization of lactic and glycolic acids. To achieve higher molecular weights, polymer chemists have developed a ring-opening polymerization method that starts with dilactide or diglycolide; hence the correct terminology is polylactide or polyglycolide. Because different forms of dilactides are possible (L or D or D,L forms), different polylactides can be produced; these include poly(L-lactide), poly(D,L-lactide), and poly(L-lactide-co-D,L-lactide). In general, the fixation devices made from these lactides retain approximately 70% of their initial strength after 9 months and approximately 50% after 12 months.
Polylactic acid and polyglycolic acid are made by condensation polymerization of lactic and glycolic acids. To achieve higher molecular weights, polymer chemists have developed a ring-opening polymerization method that starts with dilactide or diglycolide; hence the correct terminology is polylactide or polyglycolide. Because different forms of dilactides are possible (L or D or D,L forms), different polylactides can be produced; these include poly(L-lactide), poly(D,L-lactide), and poly(L-lactide-co-D,L-lactide). In general, the fixation devices made from these lactides retain approximately 70% of their initial strength after 9 months and approximately 50% after 12 months. 3, 12 Biodegradation of lactides can be accelerated by incorporation of a glycolide. When manufactured from an 85:15 ratio of D,L-lactide and glycolide, this FRP will retain approximately 70% of its initial strength after 2 weeks and approximately 50% of its strength after 6 weeks ( Figs. 1 and 2) .
When low-load bearing bones are reconstructed, the clinician can now choose between bioresorbable or permanent metallic implant materials. In addition to the obvious advantages of a temporary implant over a permanent metallic device, polymer implant materials may have the following significant benefits: 1) reduced risk of stress shielding, that is, the weakening of healing bone resulting from excessively rigid fixation; 1, 7, 8, 15, 16 2) clearer radiographic presentation of the reconstructed region due to the absence of radiographic scatter; 7,13 and 3) elimination of the need for subsequent removal surgeries that are sometimes required for metallic devices. 1, 8, 14 
CLINICAL MATERIAL AND METHODS

Materials: FRP Implants
The MacroPore/Medtronic Neurologic Technologies FRP implants were manufactured from commercially available 85:15 poly(D,L-lactide-co-glycolide) raw material by using traditional melt processing techniques. These devices were developed to service the needs of pediatric patients. The implant designs and delivery system are essentially the same as for the more slowly resorbing polymer, 70:30 poly(L-lactide-co-D,L-lactide). Table of Contents Craniofacial reconstruction with a fast resorbing polymer: a 6-to 12-month clinical follow-up review
The FRP implants used in this study were 0.75-mmthick mesh sheets ranging in size from 25 ϫ 25 mm to 100 ϫ 100 mm, and screws were 1.8 and 2.1 mm in nominal diameter. The mesh can be contoured after brief heating in sterile water (~60˚C), which brings the polymer above its glass-transition temperature (~55˚C); it can then be easily cut into any desired shape. The desired contour is maintained once the implant cools to room or body temperature. The mesh provides numerous holes with countersinks to accept the screws for fixation.
Methods: Clinical Study
After regulatory clearance from the Food and Drug Administration in August 2002, a clinical series of craniofacial reconstructions in which FRP was used was initiated to verify the efficacy of the product. The surgical use of FRP (Fig. 3 ) was similar to that for more slowly resorbing polymer implants. Detailed clinical evaluation forms were completed after surgery and at each postoperative visit. Evaluation criteria included assessment of the maintenance of fixation, healing, cosmetic appearance of the reconstruction, swelling at the implant site, and a description of any complications.
RESULTS
At present, we have completed the 6-month postoperative evaluation in 18 patients and another 11 have undergone both their 6-and 12-month postoperative evaluation, for a total of 29 patients in this report. No patient was lost to follow-up review. At surgery the mean age of the patients was 2.1 years (range 2 months-7.5 years). The diagnosis in the majority of cases was craniosynostosis (18 patients). The remaining diagnoses included fracture and fibrous dysplasia (two patients each), and cranial defect, encephalocele, orbital bone cyst, orbital lymphangioma, plagiocephaly, trigonocephaly, and Treacher-Collins syndrome (one patient each).
At the 6-and 12-month assessment all patients displayed stable fixation and bone healing. In all patients the cosmetic appearance was satisfactory or excellent, except in one with an unsatisfactory rating in whom disease progression unrelated to the implant occurred, requiring further intervention. All patients were free of postoperative swelling. Postoperative complications occurred in five patients: of these incidents, two were due to falls (mild hematoma), one was related to the patient's encephalocele (cerebrospinal fluid leak), and one was a minor bone defect (all five were treated without further surgical intervention). There was one infection following a revision, which was treated with surgical intervention. There were no material-or implant-related complications. 
DISCUSSION
Polylactide and polyglycolide resorbable polymers are biocompatible with most body tissues and have a long record of safe use in humans. In pediatric craniofacial surgery an FRP is desirable. In a series of children treated with 85:15 poly(D,L-lactide-co-glycolide) FRP implants, the 6-or 12-month postoperative evaluation was completed in 29, and all patients displayed maintenance of stable bone fixation followed by bone healing. Satisfactory or excellent cosmetic results were attained in all except one patient in whom an unsatisfactory cosmetic result occurred because of disease progression. Complications were mild and none were related to the implant. Compared with metal, the FRP implants were easier to contour, and there was no imaging interference. Theoretical advantages that need further validation include physiological load sharing and reduced growth restriction. The results of this study support the effectiveness of FRP implants in a variety of craniofacial surgical procedures including craniosynostoses, fibrous dysplasia, cranial defects, and encephaloceles.
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